Actually, ALL of the charities have been following the DCVax-L trial with incredible interest for years, including Musella. Your information is false.
And while the crazy rise in the price was based on pumping of false expectations, reasonably hoped for given the platform, the reality is that what was expected did not occur and the price went to flat YTD while the rest of the market cratered with the raising of interest rates and inflation expectations. I’d say given the content of the NYAS presentation, the rejection by various major cancer and Glioblastoma charities of the Adam Feuerstein false initial broadcast of failure, and subsequent events including the application for commercial manufacturing and further presentations by Drs Ashkan & Liau, the NYAS event was not actually a disaster, but people billing it as such sure might get their money’s worth if they can get that price down falsely and buy before major news hits the larger world.
The Musella Foundation has articles about various positive events involving DCVax-L going back many years if anyone wants to actually do some basic DD instead of dismissing anyone they do not want to hear from.
News 
Market Data 
Discover 
